# How to Prevent Heart Failure Readmission by Using Lung Impedance Device (HOPE-HF Study)

> **NCT04080388** · PHASE3 · UNKNOWN · sponsor: **Hillel Yaffe Medical Center** · enrollment: 200 (estimated)

## Conditions studied

- Heart Failure Acute

## Interventions

- **DIAGNOSTIC_TEST:** Lung Impedance Device
- **DRUG:** Anti-congestive treatment

## Key facts

- **NCT ID:** NCT04080388
- **Lead sponsor:** Hillel Yaffe Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-09
- **Primary completion:** 2021-09
- **Final completion:** 2021-09
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2019-09-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04080388

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04080388, "How to Prevent Heart Failure Readmission by Using Lung Impedance Device (HOPE-HF Study)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04080388. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*